ReP USP - Resultado da busca

Trabalho de evento-resumo
Development and application of liposomes prepared from bixin (2011)
Kikuchi, Irene Satiko ; Takamoto, Rafael Teruiti de Oliveira; Matuo, Míriam Cristina Sakuragui; Pinto, Terezinha de Jesus Andreoli
Source: Abstracts. Conference titles: CRS Annual Meeting & Exposition. Unidade: FCF
Subjects: LIPOSSOMOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIKUCHI, Irene Satiko et al. Development and application of liposomes prepared from bixin. 2011, Anais.. St. Paul: Controlled Reliase Society, 2011. . Acesso em: 13 nov. 2024.
APA
Kikuchi, I. S., Takamoto, R. T. de O., Matuo, M. C. S., & Pinto, T. de J. A. (2011). Development and application of liposomes prepared from bixin. In Abstracts. St. Paul: Controlled Reliase Society.
NLM
Kikuchi IS, Takamoto RT de O, Matuo MCS, Pinto T de JA. Development and application of liposomes prepared from bixin. Abstracts. 2011 ;[citado 2024 nov. 13 ]
Vancouver
Kikuchi IS, Takamoto RT de O, Matuo MCS, Pinto T de JA. Development and application of liposomes prepared from bixin. Abstracts. 2011 ;[citado 2024 nov. 13 ]
Trabalho de evento-resumo
Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers (2008)
Rocha, Adriana; Coelho, Eduardo Barbosa; Sampaio, S. A.; Lanchote, Vera Lúcia
Source: Abstracts. Conference titles: World Conference on Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP
Assunto: FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Adriana et al. Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. 2008, Anais.. Quebec: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2008. . Acesso em: 13 nov. 2024.
APA
Rocha, A., Coelho, E. B., Sampaio, S. A., & Lanchote, V. L. (2008). Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. In Abstracts. Quebec: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Vancouver
Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Trabalho de evento-resumo
Enantioselective pharmacokinetics of carvedilol in patients with chronic Chagas disease (2008)
Poggi, J. C.; Cesarino, Evandro José; Costa, P. C. B.; Silva, F. G.; Paula, C. S.; Moraes Júnior, A. V.; Zanardi, A. M. T.; Lanchote, Vera Lúcia
Source: Abstracts. Conference titles: World Conference on Clinical Pharmacology and Therapeutics. Unidade: FCFRP
Subjects: DOENÇA DE CHAGAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POGGI, J. C. et al. Enantioselective pharmacokinetics of carvedilol in patients with chronic Chagas disease. 2008, Anais.. Quebec: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 2008. . Acesso em: 13 nov. 2024.
APA
Poggi, J. C., Cesarino, E. J., Costa, P. C. B., Silva, F. G., Paula, C. S., Moraes Júnior, A. V., et al. (2008). Enantioselective pharmacokinetics of carvedilol in patients with chronic Chagas disease. In Abstracts. Quebec: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.
NLM
Poggi JC, Cesarino EJ, Costa PCB, Silva FG, Paula CS, Moraes Júnior AV, Zanardi AMT, Lanchote VL. Enantioselective pharmacokinetics of carvedilol in patients with chronic Chagas disease. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Vancouver
Poggi JC, Cesarino EJ, Costa PCB, Silva FG, Paula CS, Moraes Júnior AV, Zanardi AMT, Lanchote VL. Enantioselective pharmacokinetics of carvedilol in patients with chronic Chagas disease. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Trabalho de evento-resumo
Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers (2008)
Boralli, V. B.; Sampaio, S. A.; Marques, M. P.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Abstracts. Conference titles: World Conference on Clinical Pharmacology and Therapeutics. Unidades: FMRP, FCFRP
Assunto: FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORALLI, V. B. et al. Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers. 2008, Anais.. Quebec: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2008. . Acesso em: 13 nov. 2024.
APA
Boralli, V. B., Sampaio, S. A., Marques, M. P., Coelho, E. B., & Lanchote, V. L. (2008). Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers. In Abstracts. Quebec: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Boralli VB, Sampaio SA, Marques MP, Coelho EB, Lanchote VL. Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Vancouver
Boralli VB, Sampaio SA, Marques MP, Coelho EB, Lanchote VL. Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Trabalho de evento-resumo
Pharmacokinetics of carvedilol enantiomers in patients with hypertension undergoing continuous ambulatory peritoneal dialysis (2008)
Silva, F. G.; Poggi, J. C.; Marques, M. P.; Antônio, S. R. de; Costa, José Abrão Cardeal da; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: Abstracts. Conference titles: World Conference on Clinical Pharmacology and Therapeutics. Unidades: FMRP, FCFRP
Assunto: FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, F. G. et al. Pharmacokinetics of carvedilol enantiomers in patients with hypertension undergoing continuous ambulatory peritoneal dialysis. 2008, Anais.. Quebec: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2008. . Acesso em: 13 nov. 2024.
APA
Silva, F. G., Poggi, J. C., Marques, M. P., Antônio, S. R. de, Costa, J. A. C. da, Coelho, E. B., & Lanchote, V. L. (2008). Pharmacokinetics of carvedilol enantiomers in patients with hypertension undergoing continuous ambulatory peritoneal dialysis. In Abstracts. Quebec: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Silva FG, Poggi JC, Marques MP, Antônio SR de, Costa JAC da, Coelho EB, Lanchote VL. Pharmacokinetics of carvedilol enantiomers in patients with hypertension undergoing continuous ambulatory peritoneal dialysis. Abstracts. 2008 ;[citado 2024 nov. 13 ]
Vancouver
Silva FG, Poggi JC, Marques MP, Antônio SR de, Costa JAC da, Coelho EB, Lanchote VL. Pharmacokinetics of carvedilol enantiomers in patients with hypertension undergoing continuous ambulatory peritoneal dialysis. Abstracts. 2008 ;[citado 2024 nov. 13 ]

USP Schools

ReP

Filtros

Authors

USP affiliated authors